Role of major resection in pulmonary metastasectomy for colorectal cancer in the Spanish prospective multicenter study (GECMP-CCR)

Hernández, J. ; Molins, L. ; Fibla, J.J. ; Heras, F. ; Embún, R. (Universidad de Zaragoza) ; Rivas, J.J. ; Rivas, Juan J. (Universidad de Zaragoza) ; Molins, Laureano ; Embún, Raúl ; Rivas, Francisco ; Hernández, Jorge ; Mier, José Manuel ; Heras, Félix ; de la Cruz, Javier ; Rubio, Matilde ; Fernández, Esther ; Carbajo, Miguel ; Peñalver, Rafael ; Jarabo, JoséRamón ; González-Rivas, Diego ; Bolufer, Sergio ; Pagás, Carlos ; Call, Sergi ; Smith, David ; Wins, Richard ; Arnau, Antonio ; Arroyo, Andrés ; Marrón, M.Carmen ; Tamura, Akiko ; Blanco, Montse ; de Olaiz, Beatriz ; Muñoz, Gemma ; García Prim, José M. ; Rombolá, Carlos ; Barajas, Santiago García ; Rodríguez, Alberto ; Freixinet, Jorge ; Ruiz, Javier ; Carriquiry, Guillermo ; Rosenberg, Moisés ; Canalís, Emilio

Resumen: Background
Patients with pulmonary metastases from colorectal cancer (CRC) may benefit from aggressive surgical therapy. The objective of this study was to determine the role of major anatomic resection for pulmonary metastasectomy to improve survival when compared with limited pulmonary resection.
Patients and methods
Data of 522 patients (64.2% men, mean age 64.5 years) who underwent pulmonary resections with curative intent for CRC metastases over a 2-year period were reviewed. All patients were followed for a minimum of 3 years. Disease-specific survival (DSS) and disease-free survival (DFS) were assessed with the Kaplan–Meier method. Factors associated with DSS and DFS were analyzed using a Cox proportional hazards regression model.
Results
A total of 394 (75.6%) patients underwent wedge resection, 19 (3.6%) anatomic segmentectomy, 5 (0.9%) lesser resections not described, 100 (19.3%) lobectomy, and 4 (0.8%) pneumonectomy. Accordingly, 104 (19.9%) patients were treated with major anatomic resection and 418 (80.1%) with lesser resection. Operations were carried out with video-assisted thoracoscopic surgery (VATS) in 93 patients. The overall DSS and DFS were 55 and 28.3 months, respectively. Significant differences in DSS and DFS in favor of major resection versus lesser resection (DSS median not reached versus 52.2 months, P = 0.03; DFS median not reached versus 23.9 months, P < 0.001) were found. In the multivariate analysis, major resection appeared to be a protective factor in DSS [hazard ratio (HR) 0.6, 95% confidence interval (CI) 0.41–0.96, P = 0.031] and DFS (HR 0.5, 95% CI 0.36–0.75, P < 0.001). The surgical approach (VATS versus open surgical resection) had no effect on outcome.
Conclusion
Major anatomic resection with lymphadenectomy for pulmonary metastasectomy can be considered in selected CRC patient with sufficient functional reserve to improve the DSS and DFS. Further prospective randomized studies are needed to confirm the present results.

Idioma: Inglés

DOI: 10.1093/annonc/mdw064

Año: 2016

Publicado en: ANNALS OF ONCOLOGY 27, 5 (2016), 850-855
ISSN: 0923-7534

Factor impacto JCR: 11.855 (2016)

Categ. JCR: ONCOLOGY rank: 10 / 217 = 0.046 (2016) - Q1 - T1

Factor impacto SCIMAGO: 5.096 - Hematology (Q1) - Oncology (Q1) - Medicine (miscellaneous) (Q1)

Tipo y forma: Artículo (Versión definitiva)

Área (Departamento): Área Cirugía (Dpto. Cirugía,Ginecol.Obstetr.)